---
figid: PMC2945784__gb-2010-11-8-r82-2
figlink: /pmc/articles/PMC2945784/figure/F2/
number: Figure 2
caption: 'Cancer signaling pathways affected within the tumor. (a) Pre-treatment:
  overall, the down-regulation of PTEN and up-regulation of the RET signaling pathway
  appear to be driving tumor proliferation. Increased signaling independent of EGFR
  is consistent with the observed erlotinib insensitivity of the tumor. (b) Post-versus
  pre-treatment: after treatment with the RET inhibitors sunitinib and sorafenib,
  there is a marked increase in the signaling of pathway constituents, increasing
  tumor proliferation. Black and red pathway arrows represent activation and inhibition,
  respectively. Dotted arrows represent indirect interactions. The number of arrows
  denoting significantly over- or under-expressed genes are quantified using fold
  change of tumor versus compendium in (a), and primary tumor versus the tumor recurrence
  in (b): 1 arrow is FC ≥2; 2 arrows is FC ≥10; and 3 arrows is FC ≥50. CNV, copy
  number variation.'
pmcid: PMC2945784
papertitle: Evolution of an adenocarcinoma in response to selection by targeted kinase
  inhibitors.
reftext: Steven JM Jones, et al. Genome Biol. 2010;11(8):R82-R82.
pmc_ranked_result_index: '4777'
pathway_score: 0.940461
filename: gb-2010-11-8-r82-2.jpg
figtitle: Cancer signaling pathways affected within the tumor
year: '2010'
organisms: Homo sapiens
ndex: a21f538f-deff-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2945784__gb-2010-11-8-r82-2.html
  '@type': Dataset
  description: 'Cancer signaling pathways affected within the tumor. (a) Pre-treatment:
    overall, the down-regulation of PTEN and up-regulation of the RET signaling pathway
    appear to be driving tumor proliferation. Increased signaling independent of EGFR
    is consistent with the observed erlotinib insensitivity of the tumor. (b) Post-versus
    pre-treatment: after treatment with the RET inhibitors sunitinib and sorafenib,
    there is a marked increase in the signaling of pathway constituents, increasing
    tumor proliferation. Black and red pathway arrows represent activation and inhibition,
    respectively. Dotted arrows represent indirect interactions. The number of arrows
    denoting significantly over- or under-expressed genes are quantified using fold
    change of tumor versus compendium in (a), and primary tumor versus the tumor recurrence
    in (b): 1 arrow is FC ≥2; 2 arrows is FC ≥10; and 3 arrows is FC ≥50. CNV, copy
    number variation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - RAF1
  - PIK3R6
  - PDPK1
  - PIK3R5
  - PIK3R4
  - AKT2
  - EGFR
  - GFRA1
  - AKT1
  - PDGFA
  - SOST
  - RB1
  - LEP
  - PDGFRB
  - PTEN
  - TP53
  - SOS1
  - PIK3CA
  - RET
  - RPTOR
  - HRAS
  - PDGFRA
  - NRTN
  - PIK3CD
  - PIK3CG
  - SHC1
  - SHC3
  - EGF
  - MAP2K1
  - PIK3CB
  - NKX3-1
  - SHC4
  - PDGFB
  - PIK3R3
  - SHC2
  - MTOR
  - Cancer
  - Lung cancer
genes:
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PDPK1
  symbol: PDPK1
  source: hgnc_symbol
  hgnc_symbol: PDPK1
  entrez: '5170'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT2
  symbol: AKT2
  source: hgnc_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GFRA1
  symbol: GFRA1
  source: hgnc_symbol
  hgnc_symbol: GFRA1
  entrez: '2674'
- word: AKT1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDGFA
  symbol: PDGFA
  source: hgnc_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: (sost
  symbol: SOST
  source: hgnc_symbol
  hgnc_symbol: SOST
  entrez: '50964'
- word: Rb1
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
- word: obs
  symbol: OBS
  source: hgnc_prev_symbol
  hgnc_symbol: LEP
  entrez: '3952'
- word: PDGFRB
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: (sos1
  symbol: SOS1
  source: hgnc_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RET
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: RPTOR
  symbol: RPTOR
  source: hgnc_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: HRAS
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: NRTN
  symbol: NRTN
  source: hgnc_symbol
  hgnc_symbol: NRTN
  entrez: '4902'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: (SHCA
  symbol: ShcA
  source: hgnc_alias_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: (SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: (SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NKX3-1
  symbol: NKX3-1
  source: hgnc_symbol
  hgnc_symbol: NKX3-1
  entrez: '4824'
- word: (SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: PDGFB
  symbol: PDGFB
  source: hgnc_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: (SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
